Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galili, U.
Right arrow Articles by Radic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galili, U.
Right arrow Articles by Radic, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody

U Galili, F Anaraki, A Thall, C Hill-Black and M Radic

Department of Microbiology and Immunology, Medical College of Pennsylvania, Philadelphia 19129.

The natural anti-Gal antibody constitutes 1% of circulating IgG in humans and interacts specifically with the carbohydrate epitope Gal alpha 1-3Gal beta 1-4GlcNAc-R (the alpha-galactosyl epitope). In view of the unusually large amounts of this antibody in the serum, it was of interest to determine the proportion of circulating B lymphocytes capable of synthesizing anti-Gal. For this purpose, blood B lymphocytes were incubated with Epstein-Barr virus (EBV) and plated in microtiter wells. Proliferation of the EBV transformed B lymphocytes was readily visible after 3 weeks of incubation. The supernatants from wells containing proliferating B-lymphoid clones were assayed for anti-Gal by an agglutination assay with rabbit red blood cells and the specificity of the agglutinating antibodies was further confirmed by their interaction with synthetic oligosaccharides and by enzyme-linked immunosorbent assay with glycoproteins. Approximately 5% of the wells contained anti-Gal antibodies. Limiting dilution studies and IgH gene rearrangement patterns suggested that each well contained an average of five proliferating B-lymphoid clones. Thus, it is concluded that approximately 1% of circulating B lymphocytes are capable of producing anti-Gal. The proportion of anti-Gal--producing lymphoid clones exceeds by fourfold that of clones producing anti-blood group A or anti-blood group B antibodies. Individual anti-Gal clones display fine variations in their combining site, as indicated by their differential interaction with alpha-galactosyl epitopes on glycolipids and on N-linked carbohydrate chains of glycoproteins. The high frequency of precursor B lymphocytes capable of producing anti-Gal, found in every individual and the restricted specificity of this antibody to alpha-galactosyl epitopes, potentially makes anti-Gal--producing lymphocytes an effective system for studying human Ig genes involved in the natural immune response to structurally defined haptens.

Volume 82, Issue 8, pp. 2485-2493, 10/15/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
V. Padler-Karavani, H. Yu, H. Cao, H. Chokhawala, F. Karp, N. Varki, X. Chen, and A. Varki
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
Glycobiology, October 1, 2008; 18(10): 818 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Benatuil, J. Kaye, N. Cretin, J. G. Godwin, A. Cariappa, S. Pillai, and J. Iacomini
Ig Knock-In Mice Producing Anti-Carbohydrate Antibodies: Breakthrough of B Cells Producing Low Affinity Anti-Self Antibodies
J. Immunol., March 15, 2008; 180(6): 3839 - 3848.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. Mehta, R. E. Long, M. A. Comunale, M. Wang, L. Rodemich, J. Krakover, R. Philip, J. A. Marrero, R. A. Dwek, and T. M. Block
Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis
J. Virol., February 1, 2008; 82(3): 1259 - 1270.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Al-Mohanna, S. Saleh, R. S. Parhar, K. Khabar, and K. Collison
Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed
J. Leukoc. Biol., July 1, 2005; 78(1): 51 - 61.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. M. Mohiuddin, H. Ogawa, D.-P. Yin, and U. Galili
Tolerance induction to a mammalian blood group--like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells
Blood, July 1, 2003; 102(1): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. C. Unfer, D. Hellrung, and C. J. Link Jr.
Immunity to the {alpha}(1,3)Galactosyl Epitope Provides Protection in Mice Challenged with Colon Cancer Cells Expressing {alpha}(1,3)Galactosyl-transferase: A Novel Suicide Gene for Cancer Gene Therapy
Cancer Res., March 1, 2003; 63(5): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Sheikh, R. Parhar, and F. Al-Mohanna
Rapid static adhesion of human naive neutrophil to naive xenoendothelium under physiologic flow is independent of Gal{alpha}1,3-gal structures
J. Leukoc. Biol., June 1, 2002; 71(6): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Fox-Marsh and L. C. Harrison
Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system
J. Leukoc. Biol., March 1, 2002; 71(3): 401 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Cretin, J. Bracy, K. Hanson, and J. Iacomini
The Role of T Cell Help in the Production of Antibodies Specific for Gal{alpha}1-3Gal
J. Immunol., February 1, 2002; 168(3): 1479 - 1483.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Pereira-Chioccola, A Acosta-Serrano, I Correia de Almeida, M. Ferguson, T Souto-Padron, M. Rodrigues, L. Travassos, and S Schenkman
Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies
J. Cell Sci., January 4, 2000; 113(7): 1299 - 1307.
[Abstract] [PDF]


Home page
J. Immunol.Home page
I. Vallee, J.-M. Guillaumin, G. Thibault, Y. Gruel, Y. Lebranchu, P. Bardos, and H. Watier
Human T Lymphocyte Proliferative Response to Resting Porcine Endothelial Cells Results from an HLA-Restricted, IL-10-Sensitive, Indirect Presentation Pathway But Also Depends on Endothelial-Specific Costimulatory Factors
J. Immunol., August 15, 1998; 161(4): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Thall, P. Malư, and J. B. Lowe
Oocyte Galalpha1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse
J. Biol. Chem., September 15, 1995; 270(37): 21437 - 21440.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Keusch, S. M. Manzella, K. A. Nyame, R. D. Cummings, and J. U. Baenziger
Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids
J. Biol. Chem., August 11, 2000; 275(33): 25308 - 25314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chen, Z. Liu, J. Wang, J. Fang, H. Fan, and P. G. Wang
Changing the Donor Cofactor of Bovine alpha 1,3-Galactosyltransferase by Fusion with UDP-galactose 4-Epimerase. MORE EFFICIENT BIOCATALYSIS FOR SYNTHESIS OF alpha -Gal EPITOPES
J. Biol. Chem., October 6, 2000; 275(41): 31594 - 31600.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020